Follow the 恩威医药 share price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 恩威医药 has logged 1 public disclosures. Market capitalisation: €2bn. The latest transaction was disclosed on 26 August 2025 (Sale). Among the most active insiders: 陈磊. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
恩威医药 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative pharmaceutical products.